nefazodone
CONCLUSION: Depressed HIV-seropositive outpatients respond to       nefazodone comparably to other outpatient populations and have few adverse       effects, suggesting that nefazodone may have a role in the treatment of       depression in HIV-seropositive patients.
CONCLUSION: Depressed HIV-seropositive outpatients respond to       nefazodone comparably to other outpatient populations and have few adverse       effects, suggesting that  @SUBJECT$  may have a role in the  @PREDICAT$  of        @OBJECT$  in HIV-seropositive patients.